Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1,800,000 Profiles
More than 3,500 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Steven de Jong

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.8 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Procedures

Physiology

Neoplasm Drug Resistance

Anatomy

Tumor Cell Line

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Duiker Evelien W; van der Zee Ate G J; de Graeff Pauline; Boersma-van Ek Wytske; Hollema Harry; de Bock Geertruida H; de Jong Steven; de Vries Elisabeth G E
The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer.
Maduro John H; Noordhuis Maartje G; ten Hoor Klaske A; Pras Elisabeth; Arts Henriette J G; Eijsink Jasper J H; Hollema Harry; Mom Constantijne H; de Jong Steven; de Vries Elisabeth G E; de Bock Geertruida H; van der Zee Ate G J
The prognostic value of TRAIL and its death receptors in cervical cancer.
Rikhof B; van Doorn J; Suurmeijer A J H; Rautenberg M W; Groenen P J T A; Verdijk M A J; Jager P L; de Jong S; Gietema J A; van der Graaf W T A
Insulin-like growth factors and insulin-like growth factor-binding proteins in relation to disease status and incidence of hypoglycaemia in patients with a gastrointestinal stromal tumour.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Steven de Jong (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2010: Duiker Evelien W; van der Zee Ate G J; de Graeff Pauline; Boersma-van Ek Wytske; Hollema Harry; de Bock Geertruida H; de Jong Steven; de Vries Elisabeth G E
The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer.
Gynecologic oncology 2010;116(3):549-55.
2009: Maduro John H; Noordhuis Maartje G; ten Hoor Klaske A; Pras Elisabeth; Arts Henriette J G; Eijsink Jasper J H; Hollema Harry; Mom Constantijne H; de Jong Steven; de Vries Elisabeth G E; de Bock Geertruida H; van der Zee Ate G J
The prognostic value of TRAIL and its death receptors in cervical cancer.
International journal of radiation oncology, biology, physics 2009;75(1):203-11.
2009: Rikhof B; van Doorn J; Suurmeijer A J H; Rautenberg M W; Groenen P J T A; Verdijk M A J; Jager P L; de Jong S; Gietema J A; van der Graaf W T A
Insulin-like growth factors and insulin-like growth factor-binding proteins in relation to disease status and incidence of hypoglycaemia in patients with a gastrointestinal stromal tumour.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(9):1582-8.
2009: Koornstra Jan J; de Jong Steven; Boersma-van Eck Wietske; Zwart Nynke; Hollema Harry; de Vries Elisabeth G E; Kleibeuker Jan H
Fas ligand expression in lynch syndrome-associated colorectal tumours.
Pathology oncology research : POR 2009;15(3):399-406.
2009: de Graeff P; Crijns A P G; de Jong S; Boezen M; Post W J; de Vries E G E; van der Zee A G J; de Bock G H
Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis.
British journal of cancer 2009;101(1):149-59.
2009: Duiker Evelien W; de Vries Elisabeth G E; Mahalingam Devalingam; Meersma Gert Jan; Boersma-van Ek Wytske; Hollema Harry; Lub-de Hooge Marjolijn N; van Dam Go M; Cool Robbert H; Quax Wim J; Samali Afshin; van der Zee Ate G J; de Jong Steven
Enhanced antitumor efficacy of a DR5-specific TRAIL variant over recombinant human TRAIL in a bioluminescent ovarian cancer xenograft model.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(6):2048-57.
2009: Rikhof Bart; de Jong Steven; Suurmeijer Albert J H; Meijer Coby; van der Graaf Winette T A
The insulin-like growth factor system and sarcomas.
The Journal of pathology 2009;217(4):469-82.
2009: Crijns Anne P G; Fehrmann Rudolf S N; de Jong Steven; Gerbens Frans; Meersma Gert Jan; Klip Harry G; Hollema Harry; Hofstra Robert M W; te Meerman Gerard J; de Vries Elisabeth G E; van der Zee Ate G J
Survival-related profile, pathways, and transcription factors in ovarian cancer.
PLoS medicine 2009;6(2):e24.
2008: Selgrad Michael; Koornstra Jan Jacob; Fini Lucia; Blom Marloes; Huang Rong; Devol Edward B; Boersma-van Ek Wytske; Dijkstra Gerard; Verdonk Robert C; de Jong Steven; Goel Ajay; Williams Sharenda L; Meyer Richard L; Haagsma Elizabeth B; Ricciardiello Luigi; Boland C Richard
JC virus infection in colorectal neoplasia that develops after liver transplantation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(20):6717-21.
2008: de Haas Esther C; di Pietro Alessandra; Simpson Kathryn L; Meijer Coby; Suurmeijer Albert J H; Lancashire Lee J; Cummings J; de Jong Steven; de Vries Elisabeth G E; Dive Caroline; Gietema Jourik A
Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer.
Neoplasia (New York, N.Y.) 2008;10(10):1041-8.
2008: Maduro John H; de Vries Elisabeth G E; Meersma Gert-Jan; Hougardy Brigitte M T; van der Zee Ate G J; de Jong Steven
Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
International journal of radiation oncology, biology, physics 2008;72(2):543-52.
2008: Hougardy Brigitte M T; Reesink-Peters Nathalie; van den Heuvel Fiona A J; ten Hoor Klaske A; Hollema Harry; de Vries Elisabeth G E; de Jong Steven; van der Zee Ate G J
A robust ex vivo model for evaluation of induction of apoptosis by rhTRAIL in combination with proteasome inhibitor MG132 in human premalignant cervical explants.
International journal of cancer. Journal international du cancer 2008;123(6):1457-65.
2008: Oldenhuis C N A M; Stegehuis J H; Walenkamp A M E; de Jong S; de Vries E G E
Targeting TRAIL death receptors.
Current opinion in pharmacology 2008;8(4):433-9.
2008: de Graeff P; Crijns A P G; Ten Hoor K A; Klip H G; Hollema H; Oien K; Bartlett J M; Wisman G B A; de Bock G H; de Vries E G E; de Jong S; van der Zee A G J
The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer.
British journal of cancer 2008;99(2):341-9.
2008: Fehrmann Rudolf S N; de Jonge Hendrik J M; Ter Elst Arja; de Vries André; Crijns Anne G P; Weidenaar Alida C; Gerbens Frans; de Jong Steven; van der Zee Ate G J; de Vries Elisabeth G E; Kamps Willem A; Hofstra Robert M W; Te Meerman Gerard J; de Bont Eveline S J M
A new perspective on transcriptional system regulation (TSR): towards TSR profiling.
PloS one 2008;3(2):e1656.
2007: Crijns A P G; de Graeff P; Geerts D; Ten Hoor K A; Hollema H; van der Sluis T; Hofstra R M W; de Bock G H; de Jong S; van der Zee A G J; de Vries E G E
MEIS and PBX homeobox proteins in ovarian cancer.
European journal of cancer (Oxford, England : 1990) 2007;43(17):2495-505.
2007: de Groot D J A; van der Deen M; Le T K P; Regeling A; de Jong S; de Vries E G E
Indomethacin induces apoptosis via a MRP1-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRP1.
British journal of cancer 2007;97(8):1077-83.
2007: Fehrmann Rudolf S N; Li Xiang-Yi; van der Zee Ate G J; de Jong Steven; Te Meerman Gerard J; de Vries Elisabeth G E; Crijns Anne P G
Profiling studies in ovarian cancer: a review.
The oncologist 2007;12(8):960-6.
2007: de Groot D J A; de Vries E G E; Groen H J M; de Jong S
Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: from lab to clinic.
Critical reviews in oncology/hematology 2007;61(1):52-69.
2007: Heijink D M; Kleibeuker J H; Jalving M; Boersma-van Ek W; Koornstra J J; Wesseling J; de Jong S
Independent induction of caspase-8 and cFLIP expression during colorectal carcinogenesis in sporadic and HNPCC adenomas and carcinomas.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2007;29(5):409-19.
2006: van Geelen Caroline M; Westra Jantine L; de Vries Elisabeth G; Boersma-van Ek Wytske; Zwart Nynke; Hollema Harry; Boezen H Marike; Mulder Nanno H; Plukker John T; de Jong Steven; Kleibeuker Jan H; Koornstra Jan J
Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(31):4998-5004.
2006: Jalving M; Koornstra J J; Wesseling J; Boezen H M; DE Jong S; Kleibeuker J H
Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy.
Alimentary pharmacology & therapeutics 2006;24(9):1341-8.
2006: Duiker E W; Mom C H; de Jong S; Willemse P H B; Gietema J A; van der Zee A G J; de Vries E G E
The clinical trail of TRAIL.
European journal of cancer (Oxford, England : 1990) 2006;42(14):2233-40.
2006: de Graeff P; Hall J; Crijns A P G; de Bock G H; Paul J; Oien K A; ten Hoor K A; de Jong S; Hollema H; Bartlett J M S; Brown R; van der Zee A G J
Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies.
British journal of cancer 2006;95(5):627-33.
2006: Jalving Mathilde; de Jong Steven; Koornstra Jan J; Boersma-van Ek Wytske; Zwart Nynke; Wesseling Jelle; de Vries Elisabeth G E; Kleibeuker Jan H
TRAIL induces apoptosis in human colorectal adenoma cell lines and human colorectal adenomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(14 Pt 1):4350-6.
2006: Fokkema Eelco; Timens Wim; de Vries Elisabeth G E; de Jong Steven; Fidler Vaclav; Meijer Coby; Groen Harry J M
Expression and prognostic implications of apoptosis-related proteins in locally unresectable non-small cell lung cancers.
Lung cancer (Amsterdam, Netherlands) 2006;52(2):241-7.
2006: de Vries Elisabeth G E; Gietema Jourik A; de Jong Steven
Tumor necrosis factor-related apoptosis-inducing ligand pathway and its therapeutic implications.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(8):2390-3.
2006: Hougardy Brigitte M T; Maduro John H; van der Zee Ate G J; de Groot Derk Jan A; van den Heuvel Fiona A J; de Vries Elisabeth G E; de Jong Steven
Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis.
International journal of cancer. Journal international du cancer 2006;118(8):1892-900.
2006: Crijns A P G; Duiker E W; de Jong S; Willemse P H B; van der Zee A G J; de Vries E G E
Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 1():152-65.
2006: Crijns Anne P G; Gerbens Frans; Plantinga A Edo D; Meersma Gert Jan; de Jong Steven; Hofstra Robert M W; de Vries Elisabeth G E; van der Zee Ate G J; de Bock Geertruida H; te Meerman Gerard J
A biological question and a balanced (orthogonal) design: the ingredients to efficiently analyze two-color microarrays with Confirmatory Factor Analysis.
BMC genomics 2006;7():232.
2005: di Pietro Alessandra; Vries Elisabeth G E de; Gietema Jourik A; Spierings Diana C J; de Jong Steven
Testicular germ cell tumours: the paradigm of chemo-sensitive solid tumours.
The international journal of biochemistry & cell biology 2005;37(12):2437-56.
2005: Hougardy Brigitte M T; Maduro John H; van der Zee Ate G J; Willemse Pax H B; de Jong Steven; de Vries Elisabeth G E
Clinical potential of inhibitors of survival pathways and activators of apoptotic pathways in treatment of cervical cancer: changing the apoptotic balance.
The lancet oncology 2005;6(8):589-98.
2005: Lub-de Hooge M N; de Vries E G E; de Jong S; Bijl M
Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus.
Annals of the rheumatic diseases 2005;64(6):854-8.
2005: Koornstra Jan J; Jalving Mathilde; Rijcken Fleur E M; Westra Jantine; Zwart Nynke; Hollema Harry; de Vries Elisabeth G E; Hofstra Robert W M; Plukker John T M; de Jong Steven; Kleibeuker Jan H
Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: potential targets for apoptosis induction.
European journal of cancer (Oxford, England : 1990) 2005;41(8):1195-202.
2005: Hougardy Brigitte M T; van der Zee Ate G J; van den Heuvel Fiona A J; Timmer Tineke; de Vries Elisabeth G E; de Jong Steven
Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
Gynecologic oncology 2005;97(2):353-64.
2005: de Groot D J A; Timmer T; Spierings D C J; Le T K P; de Jong S; de Vries E G E
Indomethacin-induced activation of the death receptor-mediated apoptosis pathway circumvents acquired doxorubicin resistance in SCLC cells.
British journal of cancer 2005;92(8):1459-66.
2005: Reesink-Peters N; Hougardy B M T; van den Heuvel F A J; Ten Hoor K A; Hollema H; Boezen H M; de Vries E G E; de Jong S; van der Zee A G J
Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study.
Gynecologic oncology 2005;96(3):705-13.
2005: Jalving M; Koornstra J J; De Jong S; De Vries E G E; Kleibeuker J H
Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.
Alimentary pharmacology & therapeutics 2005;21(4):321-39.
2005: Arts Henriette J G; de Jong Steven; Hollema Harry; Ten Hoor Klaske A; de Vries Elisabeth G E; van der Zee Ate G J
Fas and Fas ligand in cyst fluids, serum and tumors of patients with benign and (borderline) malignant ovarian tumors.
International journal of oncology 2005;26(2):379-84.
2005: Van Dillen Ingrid J; Mulder Nanno H; Sluiter Wim J; Meijer Coby; De Jong Steven; Loncarek Jadranka; Mesnil Marc; De Vries Erik F J; Vaalburg Willem; Hospers Geke A P
Consequences of chemoresistance for the herpes simplex virus thymidine kinase/ganciclovir-induced bystander effect in a human small cell lung cancer cell line model.
Anticancer research 2005;25(1A):255-61.
2005: van Dillen Ingrid J; Mulder Nanno H; Sluiter Wim J; Meijer Coby; de Jong Steven; Loncarek Jadranka; Mesnil Marc; de Vries Erik F J; Vaalburg Willem; Hospers Geke A P
Influence of p53 status on the HSV-Tk/GCV-induced bystander effect in a panel of human ovarian carcinoma cell lines.
Oncology research 2005;15(3):151-9.
2004: Van Geelen Caroline M M; de Vries Elisabeth G E; de Jong Steven
Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2004;7(6):345-58.
2004: Komdeur R; Meijer C; Van Zweeden M; De Jong S; Wesseling J; Hoekstra H J; van der Graaf W T A
Doxorubicin potentiates TRAIL cytotoxicity and apoptosis and can overcome TRAIL-resistance in rhabdomyosarcoma cells.
International journal of oncology 2004;25(3):677-84.
2004: Lub-de Hooge Marjolijn N; Kosterink Jos G W; Perik Patrick J; Nijnuis Hugo; Tran Ly; Bart Joost; Suurmeijer Albert J H; de Jong Steven; Jager Pieter L; de Vries Elisabeth G E
Preclinical characterisation of 111In-DTPA-trastuzumab.
British journal of pharmacology 2004;143(1):99-106.
2004: Lub-de Hooge Marjolin N; de Jong Steven; Vermot-Desroches Claudine; Tulleken Jaap E; de Vries Elisabeth G E; Zijlstra Jan G
Endotoxin increases plasma soluble tumor necrosis factor-related apoptosis-inducing ligand level mediated by the p38 mitogen-activated protein kinase signaling pathway.
Shock (Augusta, Ga.) 2004;22(2):186-8.
2004: Spierings Diana C; de Vries Elisabeth G; Vellenga Edo; van den Heuvel Fiona A; Koornstra Jan J; Wesseling Jelle; Hollema Harry; de Jong Steven
Tissue distribution of the death ligand TRAIL and its receptors.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2004;52(6):821-31.
2004: Spierings Diana C J; de Vries Elisabeth G E; Stel Alja J; te Rietstap Nelina; Vellenga Edo; de Jong Steven
Low p21Waf1/Cip1 protein level sensitizes testicular germ cell tumor cells to Fas-mediated apoptosis.
Oncogene 2004;23(28):4862-72.
2004: Arts H J G; de Jong S; Hollema H; ten Hoor K; van der Zee A G J; de Vries E G E
Chemotherapy induces death receptor 5 in epithelial ovarian carcinoma.
Gynecologic oncology 2004;92(3):794-800.
2004: Koornstra J J; Rijcken F E M; De Jong S; Hollema H; de Vries E G E; Kleibeuker J H
Assessment of apoptosis by M30 immunoreactivity and the correlation with morphological criteria in normal colorectal mucosa, adenomas and carcinomas.
Histopathology 2004;44(1):9-17.
2003: Jalving Mathilde; Koornstra Jan J; Götz Jan M; van der Waaij Laurens A; de Jong Steven; Zwart Nynke; Karrenbeld Arend; Kleibeuker Jan H
High-grade dysplasia in sporadic fundic gland polyps: a case report and review of the literature.
European journal of gastroenterology & hepatology 2003;15(11):1229-33.
2003: Wisman G Bea A; Hollema Harry; Helder Marco N; Knol Ageeth J; Van der Meer Gretha T; Krans Mindert; De Jong Steven; De Vries Elisabeth G E; Van der Zee Ate G J
Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumours.
International journal of oncology 2003;23(5):1451-9.
2003: Jalving M; Koornstra J J; Boersma-van Ek W; de Jong S; Karrenbeld A; Hollema H; de Vries E G E; Kleibeuker J H
Dysplasia in fundic gland polyps is associated with nuclear beta-catenin expression and relatively high cell turnover rates.
Scandinavian journal of gastroenterology 2003;38(9):916-22.
2003: Schröder Carolien P; Ruiters Marcel H J; de Jong Steven; Tiebosch Anton T M G; Wesseling Jelle; Veenstra Rense; de Vries Jaap; Hoekstra Harold J; de Leij Lou F M H; de Vries Elisabeth G E
Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes.
International journal of cancer. Journal international du cancer 2003;106(4):611-8.
2003: Spierings Diana C J; de Vries Elisabeth G E; Timens Wim; Groen Harry J M; Boezen H Marike; de Jong Steven
Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(9):3397-405.
2003: van Geelen C M M; de Vries E G E; Le T K P; van Weeghel R P; de Jong S
Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines.
British journal of cancer 2003;89(2):363-73.
2003: Koornstra Jan J; Kleibeuker Jan H; van Geelen Caroline M M; Rijcken Fleur E M; Hollema Harry; de Vries Elisabeth G E; de Jong Steven
Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomas.
The Journal of pathology 2003;200(3):327-35.
2003: Spierings D C J; de Vries E G E; Vellenga E; de Jong S
Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
Cell death and differentiation 2003;10(7):808-22.
2003: Spierings Diana C J; de Vries Elisabeth G E; Vellenga Edo; de Jong Steven
The attractive Achilles heel of germ cell tumours: an inherent sensitivity to apoptosis-inducing stimuli.
The Journal of pathology 2003;200(2):137-48.
2003: Reesink-Peters N; Helder M N; Wisman G B A; Knol A J; Koopmans S; Boezen H M; Schuuring E; Hollema H; de Vries E G E; de Jong S; van der Zee A G J
Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia.
Journal of clinical pathology 2003;56(1):31-5.
2003: Koornstra J J; de Jong S; Hollema H; de Vries E G E; Kleibeuker J H
Changes in apoptosis during the development of colorectal cancer: a systematic review of the literature.
Critical reviews in oncology/hematology 2003;45(1):37-53.
2003: de Vries E G E; Timmer T; Mulder N H; van Geelen C M M; van der Graaf W T A; Spierings D C J; de Hooge M N; Gietema J A; de Jong S
Modulation of death receptor pathways in oncology.
Drugs of today (Barcelona, Spain : 1998) 2003;39 Suppl C():95-109.
2002: Fokkema Eelco; Groen Harry J M; Meijer Coby; Timens Wim; de Jong Steven; de Vries Elisabeth G E
The role of apoptosis-related genes in non-small-cell lung cancer.
Clinical lung cancer 2002;4(3):174-82.
2002: van Gorkom B A P; Timmer-Bosscha H; de Jong S; van der Kolk D M; Kleibeuker J H; de Vries E G E
Cytotoxicity of rhein, the active metabolite of sennoside laxatives, is reduced by multidrug resistance-associated protein 1.
British journal of cancer 2002;86(9):1494-500.
2002: Timmer Tineke; de Vries Elisabeth G E; de Jong Steven
Fas receptor-mediated apoptosis: a clinical application?
The Journal of pathology 2002;196(2):125-34.
2001: Schröder C P; Wisman G B; de Jong S; van der Graaf W T; Ruiters M H; Mulder N H; de Leij L F; van der Zee A G; de Vries E G
Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation.
British journal of cancer 2001;84(10):1348-53.
2001: Wisman G B; Knol A J; Helder M N; Krans M; de Vries E G; Hollema H; de Jong S; van der Zee A G
Telomerase in relation to clinicopathologic prognostic factors and survival in cervical cancer.
International journal of cancer. Journal international du cancer 2001;91(5):658-64.
2001: de Jong S; Timmer T; Heijenbrok F J; de Vries E G
Death receptor ligands, in particular TRAIL, to overcome drug resistance.
Cancer metastasis reviews 2001;20(1-2):51-6.
2000: Wisman G B; De Jong S; Meersma G J; Helder M N; Hollema H; de Vries E G; Keith W N; van der Zee A G
Telomerase in (pre)neoplastic cervical disease.
Human pathology 2000;31(10):1304-12.
1999: Asschert J G; De Vries E G; De Jong S; Withoff S; Vellenga E
Differential regulation of IL-6 promoter activity in a human ovarian-tumor cell line transfected with various p53 mutants: involvement of AP-1.
International journal of cancer. Journal international du cancer 1999;81(2):236-42.
1999: Withoff S; van der Zee A G; de Jong S; Hollema H; Smit E F; Mulder N H; de Vries E G
DNA topoisomerase IIalpha and -beta expression in human ovarian cancer.
British journal of cancer 1999;79(5-6):748-53.
1999: Sleijfer S; Le T K; de Jong S; Timmer-Bosscha H; Withoff S; Mulder N H
Combined cytotoxic effects of tumor necrosis factor-alpha with various cytotoxic agents in tumor cell lines that are drug resistant due to mutated p53.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1999;22(1):48-53.
1998: Wisman G B; Hollema H; de Jong S; ter Schegget J; Tjong-A-Hung S P; Ruiters M H; Krans M; de Vries E G; van der Zee A G
Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2238-45.
1998: Asschert J G; Vellenga E; De Jong S; de Vries E G
Mutual interactions between p53 and growth factors in cancer.
Anticancer research 1998;18(3A):1713-25.
1997: Van Waardenburg R C; Meijer C; Burger H; Nooter K; De Vries E G; Mulder N H; De Jong S
Effects of an inducible anti-sense c-myc gene transfer in a drug-resistant human small-cell-lung-carcinoma cell line.
International journal of cancer. Journal international du cancer 1997;73(4):544-50.
1997: de Graaf T W; de Jong S; de Vries E G; Mulder N H
Expression of proteins correlated with the unique cisplatin-sensitivity of testicular cancer.
Anticancer research 1997;17(1A):369-75.
1996: Withoff S; De Jong S; De Vries E G; Mulder N H
Human DNA topoisomerase II: biochemistry and role in chemotherapy resistance (review).
Anticancer research 1996;16(4A):1867-80.
1994: van der Zee A G; de Jong S; Keith W N; Hollema H; Boonstra H; de Vries E G
Quantitative and qualitative aspects of topoisomerase I and II alpha and beta in untreated and platinum/cyclophosphamide treated malignant ovarian tumors.
Cancer research 1994;54(3):749-55.
1993: de Jong S; Kooistra A J; de Vries E G; Mulder N H; Zijlstra J G
Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
Cancer research 1993;53(5):1064-71.
1993: de Jong S; Timmer-Bosscha H; de Vries E G; Mulder N H
Effect of novobiocin on cisplatin cytotoxicity and DNA interstrand cross-link formation in a cisplatin-resistant, small-cell lung carcinoma cell line.
International journal of cancer. Journal international du cancer 1993;53(1):110-7.
1991: van der Zee A G; Hollema H; de Jong S; Boonstra H; Gouw A; Willemse P H; Zijlstra J G; de Vries E G
P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide chemotherapy.
Cancer research 1991;51(21):5915-20.
1991: de Jong S; Zijlstra J G; Mulder N H; de Vries E G
Lack of cross-resistance to fostriecin in a human small-cell lung carcinoma cell line showing topoisomerase II-related drug resistance.
Cancer chemotherapy and pharmacology 1991;28(6):461-4.
1990: de Jong S; Zijlstra J G; de Vries E G; Mulder N H
Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line.
Cancer research 1990;50(2):304-9.
1990: Zijlstra J G; de Jong S; de Vries E G; Mulder N H
Topoisomerases, new targets in cancer chemotherapy.
Medical oncology and tumor pharmacotherapy 1990;7(1):11-8.
1986: Zijlstra J G; de Jong S; van de Grampel J C; de Vries E G; Mulder N H
Different type of DNA damage caused by three aziridinyl substituted cyclophosphazenes in a human small cell lung carcinoma cell line.
Cancer research 1986;46(6):2726-9.
1986: de Jong S; Zijlstra J G; Timmer-Bosscha H; Mulder N H; de Vries E G
Detection of DNA cross-links in tumor cells with the ethidium bromide fluorescence assay.
International journal of cancer. Journal international du cancer 1986;37(4):557-61.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Steven de Jong

Research Profile (preview)

Chemicals & Drugs

Disorders

Procedures

Physiology

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Steven de Jong (preview)

All Publications